{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:37:11Z","timestamp":1791844631533,"version":"4.3.4"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123289","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T19:34:38Z","timestamp":1428694478000},"page":"e0123289","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":264,"title":["Memantine Monotherapy for Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Shinji","family":"Matsunaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakao","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,10]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-beta and tau\u2014a toxic pas de deux in Alzheimer's disease","volume":"12","author":"LM Ittner","year":"2011","journal-title":"Nature reviews Neuroscience"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jpsychires.2013.04.013","article-title":"NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials","volume":"47","author":"T Kishi","year":"2013","journal-title":"Journal of psychiatric research"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/JGP.0b013e31822001a6","article-title":"Pharmacologic treatment of apathy in dementia","volume":"20","author":"K Berman","year":"2012","journal-title":"The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/gps.938","article-title":"The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence","volume":"18","author":"W Danysz","year":"2003","journal-title":"International journal of geriatric psychiatry"},{"issue":"2","key":"ref5","first-page":"CD003154","article-title":"Memantine for dementia","author":"R McShane","year":"2006","journal-title":"The Cochrane database of systematic reviews"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"WG Rosen","year":"1984","journal-title":"The American journal of psychiatry"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archneur.1994.00540130067012","article-title":"Severe impairment battery. A neuropsychological test for severely demented patients","volume":"51","author":"M Panisset","year":"1994","journal-title":"Archives of neurology"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000330032","article-title":"The efficacy of licensed-indication use of donepezil and memantine monotherapies for treating behavioural and psychological symptoms of dementia in patients with Alzheimer's disease: systematic review and meta-analysis","volume":"1","author":"IA Lockhart","year":"2011","journal-title":"Dementia and geriatric cognitive disorders extra"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"JL Cummings","year":"1994","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009","journal-title":"Bmj"},{"issue":"Suppl 1","key":"ref11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S1041610297004754","article-title":"A guide to the standardized Mini-Mental State Examination","volume":"9","author":"DW Molloy","year":"1997","journal-title":"International psychogeriatrics \/ IPA"},{"issue":"3","key":"ref12","first-page":"189","article-title":""Mini-mental state". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"MF Folstein","year":"1975","journal-title":"Journal of psychiatric research"},{"issue":"4","key":"ref13","first-page":"453","article-title":"Late phase II study of mementine hydrochloride, a new NMDA receptor antagonist, in patients with moderate to severe Alzheimer's disease","volume":"22","author":"S Kitamura","year":"2011","journal-title":"Jpn J Geriatr Psychiat"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.JGP.0000224350.82719.83","article-title":"Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial","volume":"14","author":"ER Peskind","year":"2006","journal-title":"The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/JCP.0b013e31829a876a","article-title":"Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial","volume":"33","author":"T Wang","year":"2013","journal-title":"Journal of clinical psychopharmacology"},{"issue":"7","key":"ref16","first-page":"825","article-title":"Study on the reliability of the Japanese version of the BEHAVE-AD","volume":"10","author":"T Asada","year":"1999","journal-title":"Jpn J Geriatr Psychiat"},{"issue":"4","key":"ref17","first-page":"446","article-title":"Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. Journal of the International Neuropsychological Society","volume":"11","author":"D Galasko","year":"2005","journal-title":"JINS"},{"issue":"Suppl 2","key":"ref18","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"11","author":"D Galasko","year":"1997","journal-title":"Alzheimer disease and associated disorders"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/ageing\/25.2.113","article-title":"Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale","volume":"25","author":"RS Bucks","year":"1996","journal-title":"Age and ageing"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/089198879600900404","article-title":"Clinical evaluation of global change in Alzheimer's disease: identifying consensus","volume":"9","author":"JT Olin","year":"1996","journal-title":"Journal of geriatric psychiatry and neurology"},{"issue":"Suppl 1","key":"ref21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1041610292001157","article-title":"Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality","volume":"4","author":"SG Sclan","year":"1992","journal-title":"International psychogeriatrics \/ IPA"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-severe Alzheimer's disease","volume":"366","author":"R Howard","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Controlled clinical trials"},{"key":"ref24","article-title":"Statistical power analysis in the behavioral sciences","author":"C J","year":"1988"},{"key":"ref25","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 The Cochrane Collaboration","author":"J Higgins","year":"2011"},{"issue":"7414","key":"ref26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"Bmj"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-2007-11409","article-title":"Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study","volume":"11","author":"S Bakchine","year":"2007","journal-title":"Journal of Alzheimer's disease: JAD"},{"issue":"14","key":"ref28","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"B Reisberg","year":"2003","journal-title":"The New England journal of medicine"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WAD.0b013e318065c495","article-title":"Memantine MEMMDSG. A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease","volume":"21","author":"CH van Dyck","year":"2007","journal-title":"Alzheimer disease and associated disorders"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/jnnp.2007.141648","article-title":"Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine","volume":"79","author":"R Schmidt","year":"2008","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/14656566.2014.902446","article-title":"Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan","volume":"15","author":"Y Nakamura","year":"2014","journal-title":"Expert opinion on pharmacotherapy"},{"issue":"4","key":"ref32","first-page":"464","article-title":"Phase III study of mementine hydrochloride, a new NMDA receptor antagonist, in patients with moderate to severe Alzheimer's disease","volume":"22","author":"Y Nakamura","year":"2011","journal-title":"Jpn J Geriatr Psychiat"},{"issue":"1\u20132","key":"ref33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000345989","article-title":"Transdermal is better than oral: observational research of the satisfaction of caregivers of patients with Alzheimer's disease treated with rivastigmine","volume":"35","author":"M Boada","year":"2013","journal-title":"Dementia and geriatric cognitive disorders"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:14:04Z","timestamp":1588976044000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123289"}},"subtitle":[],"editor":[{"given":"Terence J","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,10]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123289","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,10]]}}}